FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2897784688> ?p ?o ?g. }

• W2897784688 endingPage "226" @default.
• W2897784688 startingPage "220" @default.
• W2897784688 abstract "Background The intravenous thrombolysis (IVT) with recombinant tissue plasminogen activator (rt-PA) therapy is safe and efficient during the treatment of acute ischemic stroke. Nonetheless, the different outcomes among various stroke subgroups have limited data with regard to the safety and efficacy of cryptogenic stroke (CS). The present study compared the safety and efficacy when IVT with rt-PA was used for the treatment of CS and the other stroke subtypes. Methods This study classified the IVT with rt-PA patients within 4.5 hours after stroke onset, based on the trial of ORG 10172 in acute stroke treatment criteria in terms of diagnostic evaluation. The data were obtained from the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China database, a large multicenter prospective registry. A multivariable logistic regression model was employed to compare the differences between the subtypes in symptomatic intracerebral hemorrhage (sICH) within 7 days and studied the mortality and the outcome during 90 days. Results In total, 1118 patients were recruited; of these, 131 (11.7%) suffered from CS and 987 (88.3%) with the other etiology. In the CS group, patients were younger than those in the other etiology groups (P < .001). Moreover, it had a lower prevalence of previous stroke (P = .0117), receiving antiplatelet drug in 24 hours prior to thrombolysis (P = .0017), and functional independence (mRS > 1 before stroke, P = .003). The CS group had lower blood pressure (systolic blood pressure P = .0001; diastolic blood pressure; P = .0212) before thrombolysis, atrial fibrillation (P < .001), and diabetes mellitus (P = .0005). Transient ischemic attack, hypertension, hyperlipidemia, blood glucose, receiving anticoagulants in 24 hours prior to thrombolysis, and standard dosage of rt-PA were equally distributed in both groups. After the adjustment of confounders between the CS and the other subgroups, no obvious differences were observed in sICH rate and mortality (P > .05) The CS patients exhibited excellent recovery (mRS, 0-1; 63.78%) and functional independence (mRS, 0-2; 74.8%) than the large artery atherosclerosis patients. Conclusions IVT with rt-PA is a safe and effective method for the treatment of CS patients." @default.
• W2897784688 created "2018-10-26" @default.
• W2897784688 creator A5052898732 @default.
• W2897784688 creator A5063606923 @default.
• W2897784688 creator A5064395767 @default.
• W2897784688 creator A5065999911 @default.
• W2897784688 creator A5075844545 @default.
• W2897784688 creator A5078248814 @default.
• W2897784688 date "2019-01-01" @default.
• W2897784688 modified "2023-09-30" @default.
• W2897784688 title "Intravenous Thrombolysis Is Safe and Effective for the Cryptogenic Stroke in China: Data From the Thrombolysis Implementation and Monitor of Acute Ischemic Stroke in China (TIMS-China)" @default.
• W2897784688 cites W1970041416 @default.
• W2897784688 cites W2003741871 @default.
• W2897784688 cites W2036994346 @default.
• W2897784688 cites W2098032054 @default.
• W2897784688 cites W2106000052 @default.
• W2897784688 cites W2130555839 @default.
• W2897784688 cites W2132305654 @default.
• W2897784688 cites W2138595885 @default.
• W2897784688 cites W2148338093 @default.
• W2897784688 cites W2159233098 @default.
• W2897784688 cites W2160267090 @default.
• W2897784688 cites W2164763924 @default.
• W2897784688 cites W2292308933 @default.
• W2897784688 cites W2398874532 @default.
• W2897784688 cites W2407452807 @default.
• W2897784688 cites W2410517029 @default.
• W2897784688 cites W2467537272 @default.
• W2897784688 cites W2625088739 @default.
• W2897784688 cites W4255683973 @default.
• W2897784688 cites W4292339830 @default.
• W2897784688 doi "https://doi.org/10.1016/j.jstrokecerebrovasdis.2018.09.041" @default.
• W2897784688 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30366863" @default.
• W2897784688 hasPublicationYear "2019" @default.
• W2897784688 type Work @default.
• W2897784688 sameAs 2897784688 @default.
• W2897784688 citedByCount "12" @default.
• W2897784688 countsByYear W28977846882020 @default.
• W2897784688 countsByYear W28977846882021 @default.
• W2897784688 countsByYear W28977846882022 @default.
• W2897784688 crossrefType "journal-article" @default.
• W2897784688 hasAuthorship W2897784688A5052898732 @default.
• W2897784688 hasAuthorship W2897784688A5063606923 @default.
• W2897784688 hasAuthorship W2897784688A5064395767 @default.
• W2897784688 hasAuthorship W2897784688A5065999911 @default.
• W2897784688 hasAuthorship W2897784688A5075844545 @default.
• W2897784688 hasAuthorship W2897784688A5078248814 @default.
• W2897784688 hasConcept C126322002 @default.
• W2897784688 hasConcept C127413603 @default.
• W2897784688 hasConcept C134018914 @default.
• W2897784688 hasConcept C137627325 @default.
• W2897784688 hasConcept C164705383 @default.
• W2897784688 hasConcept C2777094939 @default.
• W2897784688 hasConcept C2777736543 @default.
• W2897784688 hasConcept C2779161974 @default.
• W2897784688 hasConcept C2779581417 @default.
• W2897784688 hasConcept C2780645631 @default.
• W2897784688 hasConcept C500558357 @default.
• W2897784688 hasConcept C555293320 @default.
• W2897784688 hasConcept C71924100 @default.
• W2897784688 hasConcept C78519656 @default.
• W2897784688 hasConcept C84393581 @default.
• W2897784688 hasConceptScore W2897784688C126322002 @default.
• W2897784688 hasConceptScore W2897784688C127413603 @default.
• W2897784688 hasConceptScore W2897784688C134018914 @default.
• W2897784688 hasConceptScore W2897784688C137627325 @default.
• W2897784688 hasConceptScore W2897784688C164705383 @default.
• W2897784688 hasConceptScore W2897784688C2777094939 @default.
• W2897784688 hasConceptScore W2897784688C2777736543 @default.
• W2897784688 hasConceptScore W2897784688C2779161974 @default.
• W2897784688 hasConceptScore W2897784688C2779581417 @default.
• W2897784688 hasConceptScore W2897784688C2780645631 @default.
• W2897784688 hasConceptScore W2897784688C500558357 @default.
• W2897784688 hasConceptScore W2897784688C555293320 @default.
• W2897784688 hasConceptScore W2897784688C71924100 @default.
• W2897784688 hasConceptScore W2897784688C78519656 @default.
• W2897784688 hasConceptScore W2897784688C84393581 @default.
• W2897784688 hasIssue "1" @default.
• W2897784688 hasLocation W28977846881 @default.
• W2897784688 hasLocation W28977846882 @default.
• W2897784688 hasOpenAccess W2897784688 @default.
• W2897784688 hasPrimaryLocation W28977846881 @default.
• W2897784688 hasRelatedWork W205404821 @default.
• W2897784688 hasRelatedWork W2112339078 @default.
• W2897784688 hasRelatedWork W2125605941 @default.
• W2897784688 hasRelatedWork W2136240081 @default.
• W2897784688 hasRelatedWork W2160454231 @default.
• W2897784688 hasRelatedWork W2999689684 @default.
• W2897784688 hasRelatedWork W3010099892 @default.
• W2897784688 hasRelatedWork W3151283227 @default.
• W2897784688 hasRelatedWork W4248492855 @default.
• W2897784688 hasRelatedWork W4367018668 @default.
• W2897784688 hasVolume "28" @default.
• W2897784688 isParatext "false" @default.
• W2897784688 isRetracted "false" @default.
• W2897784688 magId "2897784688" @default.
• W2897784688 workType "article" @default.